On April 27th 2023 the steering committee of the SWITCH trial discussed the progress of the trial after randomisation of more than 200 patients. After a careful evaluation of the funding resources and the recruitment rate, the steering committee decided to stop the trial due to “lack of further funding” […]

Stop of the trial